PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 13, 2026Current Drug Safety0 citations

Suspected Cutaneous Adverse Reaction Due to Oral Consumptionof Siddha Polyherbo-Mineral Formulation, Gandhaga Rasayanam:A Case Report

View Full Paper
STSubathra T.CNChandan N.MBManish Barvaliya

Key Points

  • The aim is to document a suspected adverse skin reaction due to the Siddha formulation Gandhaga Rasayanam.
  • Case report of a 36-year-old female patient
  • Observed skin lesions after GRM treatment for tinea cruris
  • Monitored patient reactions and treatment outcomes
  • Development of inflamed skin lesions after 3 days of GRM therapy
  • Lesions resolved completely after discontinuation of GRM and treatment with levocetirizine
  • No recurrence of lesions when GRM was excluded from further treatment

Abstract

Introduction: The Siddha formulation Gandhaga Rasayanam (GRM) is a classical polyherbo-mineral medicine containing purified sulphur and other herbal ingredients, including Schedule E(1) drugs. It is traditionally used to manage chronic ailments and dermatological conditions. Limited safety data have been documented for Siddha medicines; this report highlights a suspected adverse cutaneous reaction probably associated with GRM. Case Summary: A 36-year-old female treated for residual Padarthamarai (Tinea cruris) developed elevated plaque with ill-defined, diffuse borders over the neck and upper back on Day 3 of therapy with GRM in combination with other Siddha medicines. This lesion was inflamed, warm to the touch, and associated with pruritus, itching, and burning. The lesions subsided markedly upon GRM withdrawal and resolved completely after a short course of levocetirizine. The patient was advised to resume other internal medicines, excluding GRM, the most suspected drug, and no recurrence was observed. This implicates GRM as the probable cause of the adverse reaction. Conclusion: This case highlights the potential for adverse reactions even with traditionally regarded safe Ayush formulations and emphasizes the need for vigilant pharmacovigilance and systematic documentation of adverse events to ensure patient safety

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

T. et al. (2026) studied this question.

synapsesocial.com/papers/69dc892e3afacbeac03eaeeahttps://doi.org/10.2174/0115748863460961260323095447
Ask AI
Helpful
Bookmark
Share
View Full Paper